Abstract #0227
Spectroscopy as an Endpoint in Multisite Clinical Trials: Dichloroacetate Reduces Cerebral Lactate After Stroke
G.D. Graham, P.B. Barker, W.M. Brooks, D.C. Morris, D.O. Hearshen, J.A. Sanders, W. Ahmed, B.A. Holshouser and C.C. Turkel, University of New Mexico, Albuquerque, NM, USA; Henry Ford Hospital, Detroit, MI, USA; Loma Linda University, Loma Linda, CA, USA and Cypros Pharmaceutical Corp., Carlsbad, CA, USA.
